DOP2017000196A - Derivados de tetrahidropiranil benzamida - Google Patents
Derivados de tetrahidropiranil benzamidaInfo
- Publication number
- DOP2017000196A DOP2017000196A DO2017000196A DO2017000196A DOP2017000196A DO P2017000196 A DOP2017000196 A DO P2017000196A DO 2017000196 A DO2017000196 A DO 2017000196A DO 2017000196 A DO2017000196 A DO 2017000196A DO P2017000196 A DOP2017000196 A DO P2017000196A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- tetrahidropiranil
- benzamida
- derivatives
- compounds
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a compuestos de la Fórmula siguiente: en donde R, R1-R3 son como se describen en la presente; métodos para tratar pacientes por diabetes usando los compuestos, y procesos para preparar los compuestos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2015/073563 WO2016138631A1 (en) | 2015-03-03 | 2015-03-03 | Imidazo benzamide compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2017000196A true DOP2017000196A (es) | 2017-09-15 |
Family
ID=56849060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2017000196A DOP2017000196A (es) | 2015-03-03 | 2017-08-21 | Derivados de tetrahidropiranil benzamida |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US10196385B2 (es) |
| EP (1) | EP3265460A4 (es) |
| JP (1) | JP2018507232A (es) |
| KR (1) | KR20170106483A (es) |
| CN (1) | CN107406436B (es) |
| AU (1) | AU2016228055B2 (es) |
| BR (1) | BR112017015448A2 (es) |
| CA (1) | CA2975413A1 (es) |
| CL (1) | CL2017002148A1 (es) |
| CO (1) | CO2017008721A2 (es) |
| CR (1) | CR20170354A (es) |
| DO (1) | DOP2017000196A (es) |
| EA (1) | EA201791745A1 (es) |
| EC (1) | ECSP17058071A (es) |
| IL (1) | IL253405A0 (es) |
| MA (1) | MA41641A (es) |
| MX (1) | MX2017011087A (es) |
| PE (1) | PE20171650A1 (es) |
| PH (1) | PH12017501560A1 (es) |
| SG (1) | SG11201706718RA (es) |
| SV (1) | SV2017005520A (es) |
| TN (1) | TN2017000372A1 (es) |
| WO (2) | WO2016138631A1 (es) |
| ZA (1) | ZA201704948B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018014337A1 (en) | 2016-07-22 | 2018-01-25 | Eli Lilly And Company | 3-Chloro-N- [ (1R, 3S) -3- [5- (3, 5-dimethylimidazol-4-yl) -4H-1, 2, 4-triazol-3-yl] cyclohexyl] -N-methyl-benzamide |
| CA3089746A1 (en) | 2018-03-09 | 2019-09-12 | Recurium Ip Holdings, Llc | Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-ones |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007308154A1 (en) | 2006-10-10 | 2008-04-17 | Amgen Inc. | N-aryl pyrazole compounds for use against diabetes |
| US8188098B2 (en) | 2008-05-19 | 2012-05-29 | Hoffmann-La Roche Inc. | GPR119 receptor agonists |
| JP5685181B2 (ja) * | 2009-03-05 | 2015-03-18 | 塩野義製薬株式会社 | Ｎｐｙｙ５受容体拮抗作用を有するシクロヘキサン誘導体 |
| CA2785790A1 (en) * | 2010-01-15 | 2011-07-21 | Merck Sharp & Dohme Corp. | Oxadiazole beta carboline derivatives as antidiabetic compounds |
| WO2012123449A1 (en) * | 2011-03-14 | 2012-09-20 | Boehringer Ingelheim International Gmbh | N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators |
| WO2015120610A1 (en) | 2014-02-14 | 2015-08-20 | Eli Lilly And Company | Gpr142 agonist compound |
-
2015
- 2015-03-03 WO PCT/CN2015/073563 patent/WO2016138631A1/en active Application Filing
-
2016
- 2016-02-18 MA MA041641A patent/MA41641A/fr unknown
- 2016-02-19 US US15/118,295 patent/US10196385B2/en active Active
- 2016-02-19 EA EA201791745A patent/EA201791745A1/ru unknown
- 2016-02-19 BR BR112017015448A patent/BR112017015448A2/pt not_active IP Right Cessation
- 2016-02-19 WO PCT/CN2016/074083 patent/WO2016138821A1/en active Application Filing
- 2016-02-19 SG SG11201706718RA patent/SG11201706718RA/en unknown
- 2016-02-19 EP EP16758437.4A patent/EP3265460A4/en not_active Withdrawn
- 2016-02-19 CN CN201680013049.8A patent/CN107406436B/zh active Active
- 2016-02-19 TN TNP/2017/000372A patent/TN2017000372A1/en unknown
- 2016-02-19 MX MX2017011087A patent/MX2017011087A/es unknown
- 2016-02-19 JP JP2017546161A patent/JP2018507232A/ja active Pending
- 2016-02-19 KR KR1020177024303A patent/KR20170106483A/ko not_active Application Discontinuation
- 2016-02-19 AU AU2016228055A patent/AU2016228055B2/en not_active Expired - Fee Related
- 2016-02-19 PE PE2017001456A patent/PE20171650A1/es not_active Application Discontinuation
- 2016-02-19 CR CR20170354A patent/CR20170354A/es unknown
- 2016-02-19 CA CA2975413A patent/CA2975413A1/en not_active Abandoned
-
2017
- 2017-07-10 IL IL253405A patent/IL253405A0/en unknown
- 2017-07-20 ZA ZA2017/04948A patent/ZA201704948B/en unknown
- 2017-08-21 DO DO2017000196A patent/DOP2017000196A/es unknown
- 2017-08-22 SV SV2017005520A patent/SV2017005520A/es unknown
- 2017-08-23 CL CL2017002148A patent/CL2017002148A1/es unknown
- 2017-08-28 CO CONC2017/0008721A patent/CO2017008721A2/es unknown
- 2017-08-30 PH PH12017501560A patent/PH12017501560A1/en unknown
- 2017-09-01 EC ECIEPI201758071A patent/ECSP17058071A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10196385B2 (en) | 2019-02-05 |
| US20180194755A1 (en) | 2018-07-12 |
| CR20170354A (es) | 2017-09-05 |
| WO2016138631A1 (en) | 2016-09-09 |
| MA41641A (fr) | 2018-01-09 |
| SV2017005520A (es) | 2018-08-27 |
| EP3265460A4 (en) | 2018-08-08 |
| EP3265460A1 (en) | 2018-01-10 |
| WO2016138821A1 (en) | 2016-09-09 |
| EA201791745A1 (ru) | 2018-01-31 |
| CN107406436B (zh) | 2021-02-26 |
| CA2975413A1 (en) | 2016-09-09 |
| CO2017008721A2 (es) | 2018-01-05 |
| KR20170106483A (ko) | 2017-09-20 |
| JP2018507232A (ja) | 2018-03-15 |
| SG11201706718RA (en) | 2017-09-28 |
| AU2016228055B2 (en) | 2018-06-07 |
| AU2016228055A1 (en) | 2017-08-17 |
| PH12017501560A1 (en) | 2018-02-05 |
| CL2017002148A1 (es) | 2018-04-13 |
| PE20171650A1 (es) | 2017-11-13 |
| ZA201704948B (en) | 2019-02-27 |
| CN107406436A (zh) | 2017-11-28 |
| BR112017015448A2 (pt) | 2018-01-30 |
| ECSP17058071A (es) | 2017-10-31 |
| IL253405A0 (en) | 2017-09-28 |
| MX2017011087A (es) | 2017-11-10 |
| TN2017000372A1 (en) | 2019-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP17073191A (es) | Compuestos heterocíclicos como inhibidores de lsd1 | |
| CO2019008783A2 (es) | Compuestos dinucleotidos ciclicos para el tratamiento del cancer | |
| ECSP15045801A (es) | Inhibidores de la phd de 6(5hidroxi1hpirazol1il)nicotinamida | |
| UY37124A (es) | Nuevos compuestos de 6,7-dihidro-5h-benzo[7]anuleno sustituidos, procesos para su preparación y usos terapéuticos de los mismos | |
| BR112016023558A2 (pt) | compostos úteis como imunomoduladores | |
| DOP2016000144A (es) | Moduladores de tetrahidropiridopirazinas de gpr6 | |
| BR112017017396A2 (pt) | derivados substituídos de nucleosídeos substituídos úteis como agentes anticancerígenos | |
| CO2018000589A2 (es) | Oxiesteroles y composiciones farmacéuticas que los contienen | |
| CU24408B1 (es) | Compuestos de dihidroisoquinolinona sustituida | |
| ECSP15008851A (es) | Compuestos heteroaromáticos como inhibidores de btk | |
| BR112017012272A2 (pt) | derivados de 2-anilinopirimidina como moduladores de egfr | |
| UY34657A (es) | ?derivados macrocíclicos para el tratamiento de enfermedades?. | |
| TR201906366T4 (tr) | Polisiklik-karbamoilpiridon bileşiklerinin sentezi. | |
| UY36737A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| CR20170008A (es) | Compuestos de [1,2,4] triazol e imidazol sustituidos | |
| CU24608B1 (es) | Compuestos de dihidrooxadiazinonas sustituidas útiles en el tratamiento de enfermedades hiperproliferativas y métodos para preparar dichos compuestos | |
| BR112017013286A2 (pt) | composto de isoxazolina, e, uso de um composto de isoxazolina. | |
| DOP2016000211A (es) | Pirazinas moduladoras de gpr6 | |
| CY1124164T1 (el) | Καινοτομος παρασκευη και κρυσταλλωση της ιοσιμενολης | |
| PE20180219A1 (es) | Procesos para preparar fluorocetolidos | |
| BR112017016333A2 (pt) | compostos anticâncer | |
| DOP2017000196A (es) | Derivados de tetrahidropiranil benzamida | |
| BR112017012007A2 (pt) | compostos orgânicos | |
| CL2017002304A1 (es) | Métodos para tratar enfermedades | |
| CO2017007074A2 (es) | Sintesis total de trioxacarcina dc-45-a2 y preparación de analogos de trioxacarcina |